HER2 breast cancer biomarker detection using a sandwich optical fiber assay

被引:100
|
作者
Loyez, Mederic [1 ]
Lobry, Maxime [2 ]
Hassan, Eman M. [3 ,4 ]
DeRosa, Maria C. [3 ]
Caucheteur, Christophe [2 ]
Wattiez, Ruddy [1 ]
机构
[1] Univ Mons, Prote & Microbiol Dept, Pl Parc 20, B-7000 Mons, Belgium
[2] Univ Mons, Electromagnetism & Telecommun Dept, Bld Dolez 31, B-7000 Mons, Belgium
[3] Carleton Univ, Inst Biochem, 1125 Colonel By Dr, Ottawa, ON K1S 5B6, Canada
[4] Natl Res Council Canada, Metrol Res Ctr, Ottawa, ON K1A 0R6, Canada
关键词
Optical fiber; Breast cancer diagnosis; HER2; Biomarker; Aptamers; Surface plasmon resonance; FILM THICKNESS; SENSITIVITY; SPR; MULTIMODE; GRATINGS; DESIGN; SENSOR;
D O I
10.1016/j.talanta.2020.121452
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Optical fiber-based surface plasmon resonance (OF-SPR) sensors have demonstrated high versatility and performances over the last years, which propelled the technique to the heart of numerous and original biosensing concepts. In this work, we contribute to this effort and present our recent findings about the detection of breast cancer HER2 biomarkers through OF-SPR optrodes. 1 cm-long sections of 400 mu m core-diameter optical fibers were covered with a sputtered gold film, yielding enhanced sensitivity to surface refractive index changes. Studying the impacts of the gold film thickness on the plasmonic spectral response, we improved the quality and reproducibility of the sensors. These achievements were correlated in two ways, using both the central wavelengths of the plasmon resonance and its influence on the bulk refractive index sensitivity. Our dataset was fed by additional biosensing experiments with a direct and indirect approach, relying on aptamers and antibodies specifically implemented in a sandwich layout. HER2 biomarkers were specifically detected at 0.6 mu g/mL (5.16 nM) in label-free while the amplification with HER2-antibodies provided a nearly hundredfold signal magnification, reaching 9.3 ng/mL (77.4 pM). We believe that these results harbinger the way for their further use in biomedical samples.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Is HER2 ultra-low breast cancer different from HER2 null or HER2 low breast cancer? A study of 1363 patients
    Chen, Zhaoxu
    Jia, Huiqing
    Zhang, Huina
    Chen, Lifang
    Zhao, Peng
    Zhao, Jing
    Fu, Guangming
    Xing, Xiaoming
    Li, Yujun
    Wang, Chengqin
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 202 (02) : 313 - 323
  • [42] Is HER2 ultra-low breast cancer different from HER2 null or HER2 low breast cancer? A study of 1363 patients
    Zhaoxu Chen
    Huiqing Jia
    Huina Zhang
    Lifang Chen
    Peng Zhao
    Jing Zhao
    Guangming Fu
    Xiaoming Xing
    Yujun Li
    Chengqin Wang
    Breast Cancer Research and Treatment, 2023, 202 : 313 - 323
  • [43] Nitrogen-enhanced carbon quantum dots mediated immunosensor for electrochemical detection of HER2 breast cancer biomarker
    Amir, Humayun
    Subramanian, Vasanth
    Sornambikai, Sundaram
    Ponpandian, Nagamony
    Viswanathan, Chinnusamy
    BIOELECTROCHEMISTRY, 2024, 155
  • [44] Biomarker triplet NAMPT/VEGF/HER2 as a de novo detection panel for the diagnosis and prognosis of human breast cancer
    Zhu, Yanyan
    Guo, Meiyan
    Zhang, Lingyun
    Xu, Tao
    Wang, Li
    Xu, Guoxiong
    ONCOLOGY REPORTS, 2016, 35 (01) : 454 - 462
  • [45] Detection and quantification of HER2 protein using proximity ligation assay in situ
    Andersson, A. -C.
    Holmquist, G.
    Reyes, A.
    Gohl, E.
    Gullberg, M.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2007, 37 : 82 - 82
  • [46] Targeting HER2 protein in individual cells using ICP-MS detection and its potential as prognostic and predictive breast cancer biomarker
    Asensio, A. Fernandez
    Corte-Rodriguez, M.
    Bettmer, J.
    Sierra, L. M.
    Montes-Bayon, M.
    Blanco-Gonzalez, E.
    TALANTA, 2021, 235
  • [47] Studies on the Affinity-based Biosensors for Electrochemical Detection of HER2 Cancer Biomarker
    Jarczewska, Marta
    Trojan, Anita
    Gagala, Malgorzata
    Malinowska, Elzbieta
    ELECTROANALYSIS, 2019, 31 (06) : 1125 - 1134
  • [48] Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer
    Bose, Ron
    Kavuri, Shyam M.
    Searleman, Adam C.
    Shen, Wei
    Shen, Dong
    Koboldt, Daniel C.
    Monsey, John
    Goel, Nicholas
    Aronson, Adam B.
    Li, Shunqiang
    Ma, Cynthia X.
    Ding, Li
    Mardis, Elaine R.
    Ellis, Matthew J.
    CANCER DISCOVERY, 2013, 3 (02) : 224 - 237
  • [49] Quantitative determination of HER2 expression by confocal microscopy assay in CTCs of breast cancer
    Cao, Sheng
    Li, Yang
    Li, Jin
    Li, Chang-Fei
    Zhang, Wei
    Yang, Zeng-Qi
    Meng, Song-Dong
    ONCOLOGY REPORTS, 2010, 23 (02) : 423 - 428
  • [50] Evaluation of analytical accuracy of HER2 status in patients with breast cancer Comparison of HER2 GPA with HER2 IHC and HER2 FISH
    Jensen, Steffen Grann
    Thomas, Peter Engel
    Christensen, Ib Jarle
    Balslev, Eva
    Hansen, Alastair
    Hogdall, Estrid
    APMIS, 2020, 128 (11) : 573 - 582